The EVAHEART 2 LVAS is intended for patients who are at risk of imminent death due to severe left ventricular failure. It supports the left ventricle by providing continuous blood flow, helping to stabilize the patient’s condition and reduce the heart’s workload.
The EVAHEART 2 LVAS is a continuous flow left ventricular assist system developed for patients at risk of imminent death from severe left ventricular failure. It assists the heart by placing a centrifugal pump in parallel with the left ventricle, providing blood flow for the vascular system and reducing the load on the ventricle.
